The syngeneic Colon26 colorectal cancer model used in our study has low immunogenicity and few infiltrating T cells under normal conditions, resulting in a limited response to PD‐1/PD‐L1 checkpoint blockade. The gene discussed is CD274; the disease is colorectal cancer.